Skip to main content
. 2022 Nov 24;226:1116–1140. doi: 10.1016/j.ijbiomac.2022.11.227

Table 12.

Affinity and stability matured antibodies designed by Rosetta based on Bamlanivimab scaffold.

Chain Target positions <0.7 (nm) Model Chain Designed positions Score (REU)
H 28, 29, 30, 31, 32, 33, 47, 50, 52, 54, 55, 57, 58, 59, 60, 61, 65, 74, 100, 101, 102, 103, 104, 105, 106, 109, 110 1 H S30T, R50M, I54V, N59A, A103Y, Y110F −1315.52
L Q27S, S28P, S30D, S91T, T94M, R96W
2 H S30T, R50M, I54V, N59A, K74Q, A103Y, Y110F −1314.53
L Q27S, S28P, S30D, S91T, T94M, R96W
3 H S30T, R50M, I54V, N59A, A103Y, Y106W, Y110F −1312.68
L Q27S, S28P, S30D, Y32F, S91T, T94M, R96W
4 H S30T, R50M, I54V, N59A, A103Y, Y110H −1309.7
L 2, 27, 28, 29, 30, 32, 91, 92, 93, 94, 98 L Q27S, S28P, S30D, S91T, T94M, R96W
5 H S30T, R50M, I54V, A58V, N59A, A103Y, Y110F −1307.98
L Q27S, S28P, S30D, S91T, T94M, R96W
6 H S30T, N31D, Y32A, R50M, I54V, N59A, A103Y, R104K, H105N, Y110F −1305.94
L Q27S, S28P, S30D, S91T, T94M, R96W
7 H S30T, R50M, I54V, N59A, A103Y, Y110F −1305.49
L Q27T, S28E, S30G, S91T, T94M, R96W